The randomized, double-blind, placebo-controlled trial assessed the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of once-daily dosing of TERN-601, showing promising results for this small-molecule treatment
These domains catalyze two reactions once AASS is biologically active (holo-AASS)
Though not common, GLP-1 medications can trigger or worsen gastroparesis in some individuals
The 52-week exercise program included a 6-week ramp-up phase, and from weeks 7 to 52, the aim was to follow the World Health Organizations recommendations on physical activity for health, i.e., at least 150 min/week of moderate intensity, 75 min/week of vigorous intensity, or an equivalent combination of both [31]
Clin Rev Allergy Immunol
Abstract There is growing interest in the relationship between Alzheimers disease (AD) and diabetes mellitus (DM), and the glucagon-like peptide-1 receptor (GLP-1R) may be an important link between these two diseases